Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4650-4662
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4650
Figure 1
Figure 1 Kaplan-Meier survival curves stratified by γ-glutamyl transferase to albumin ratio. A: Overall survival of the transarterial chemoembolization alone cohort; B: The cohort after propensity score matching; C: Training set; D: Validation set; E: Dual therapy cohort; F: Triple therapy cohort. GAR: γ-glutamyl transferase to albumin ratio.
Figure 2
Figure 2 Nomogram constructed based on independent risk factors for predicting 1-, 2-, and 3-year overall survival in patients with hepatocellular carcinoma. GAR: γ-glutamyl transferase to albumin ratio; PVTT: Portal vein tumor thrombus.
Figure 3
Figure 3 Time-dependent receiver operating characteristic curves of this predictive model. AUC: Area under receiver operating characteristic curve.
Figure 4
Figure 4 Calibration curve of validation cohort. OS: Overall survival.
Figure 5
Figure 5  Decision curve analyses curve of validation cohort.